EnVVeno Medical Corporation (NVNO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for EnVVeno Medical Corporation (NVNO:NASDAQ), powered by AI.

Current Price
$10.00
P/E Ratio
-0.3
Market Cap
6M
Sector
Healthcare
What is the EnVVeno Medical Corporation stock price forecast?

EnVVeno Medical Corporation is currently trading at $10.00. View real-time AI analysis on Alpha Lenz.

What is EnVVeno Medical Corporation insider trading activity?

View the latest insider trading data for EnVVeno Medical Corporation on Alpha Lenz.

What is EnVVeno Medical Corporation's P/E ratio?

EnVVeno Medical Corporation's P/E ratio is -0.3.

EnVVeno Medical Corporation

NASDAQ · NVNO
$10.00-0.23(-2.25%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about EnVVeno Medical Corporation's future dividend policy...
Alpha Chat Insight

EnVVeno Medical Corporation trades at a P/E of -0.3 (undervalued) with modest ROE of -56.2%.

Ask for details

Company Overview

EnVVeno Medical Corporation is a biomedical company focused on the development and commercialization of innovative medical treatments. Primarily, the corporation is dedicated to addressing unmet medical needs pertaining to vascular diseases, with a notable emphasis on venous conditions. The company's flagship product centers around a specialized prosthetic device aimed at treating chronic venous insufficiency (CVI), a condition prevalent due to valve failure in veins, leading to poor circulation and various complications. EnVVeno Medical's research and development efforts are channeled towards creating effective solutions that improve patient outcomes and enhance quality of life for individuals affected by these vascular issues. Operating within the healthcare and biotechnology sector, EnVVeno Medical is a key contributor to advancements in medical technology, with its innovative approach underscoring its importance in the medical devices market. By prioritizing cardiovascular health, the corporation plays a critical role in the healthcare industry, supporting the broader objective of developing cutting-edge treatments and addressing critical health challenges.

CEOMr. Robert A. Berman
SectorHealthcare
IndustryMedical Devices
Employees37

Company Statistics

FY 2025

Profile

$5.89MMarket Cap
$0.00Revenue
0.00Shares Out
37Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.30P/E
0.22P/B
N/AEV/Sales
-0.17EV/EBITDA
-0.38P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-52.26%ROA
-56.21%ROE
-56.09%ROIC

Financial Health

$3.06MCash & Cash Equivalents
$-633.00KNet Debt
8.96%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

EnVVeno Medical Corporation (ticker: NVNO) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 37 employees. Market cap is $6M.

The current price is $10 with a P/E ratio of -0.3x and P/B of 0.22x.

ROE is -56.21%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
EnVVeno Medical Corporation (NVNO) Stock Forecast 2026 $10.00 — Price, Financials & Analyst Targets | Alpha Lenz